Skip to content
Screener

Teladoc Health TDOC Q2 2025 earnings

Reported July 29, 2025 · After market close

Revenue$631.9MBeat by $4.2M
EPS-$0.19Beat by $0.08
Revenue estimate$627.7M
EPS estimate-$0.27

Next report

Oct 28, 2026 (in a month)
Revenue estimate$590.3M
EPS estimate-$0.23

Financials

Q2 2025

Income statement

See full
Revenue$631.9M-1.6%
Gross profit$441.4M-2.9%
Operating income-$54.4M+93.5%
Net income-$32.7M+96.1%
EPS (diluted)-$0.19+96.1%

Balance sheet

See full
Cash & equivalents$679.6M-41.5%
Total debt$41.9M-93.0%
Total equity$1.4B-5.3%
Total assets$2.9B-17.9%

Cash flow

See full
Operating cash flow$91.4M+3.1%
CapEx$1.3M-33.7%
Free cash flow$90.2M+3.9%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.4B-14.4%
Enterprise value$765.78M-28.9%
P/S0.6×-0.1×

Profitability

See full
Gross margin70.3%-0.5pp
Operating margin-10.5%-4.5pp
Net margin-8.2%-3.6pp
FCF margin11.5%-0.9pp

Returns & leverage

See full
Return on equity-14.2%-6.0pp
Debt / equity0×-0.4×
Current ratio2.7×+1.0×

Segments

By segment

See full
Integrated Care$391.5M+3.7%
BetterHelp$240.4M-9.3%

By product

See full
Access Fees$523.7M-6.4%
Other$108.2M+30.7%

FAQ

When did Teladoc Health report Q2 2025 earnings?
Teladoc Health (TDOC) reported Q2 2025 earnings on July 29, 2025 after market close.
What were Teladoc Health's Q2 2025 revenue and EPS?
Teladoc Health reported revenue of $631.9M and eps of $-0.19 for Q2 2025.
Did Teladoc Health beat estimates in Q2 2025?
Revenue beat the consensus estimate of $627.7M by $4.2M. EPS beat the consensus estimate of $-0.27 by $0.08.
How did Teladoc Health's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.6% from $642.4M a year earlier and eps grew 32.1% from $-0.28.
Where can I find Teladoc Health's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001477449-25-000096) and the 10-Q periodic report (0001477449-25-000099) directly on SEC EDGAR. The filing index links above go to sec.gov.